Physician profile
Perry Lee Fleisher
NPI 1992704324
$1,756.64
in general payments reported to CMS, 2019-2025
15 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $33.60 · 2021: $447 · 2022: $64.77 · 2023: $171 · 2024: $469 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $532.19 | 2021-2025 | Linq II, Mycarelink, Cobalt Dr Mri Surescan |
| Kestra Medical Technology Services, INC. | $343.98 | 2023-2024 | Assure Wcd |
| Amgen INC. | $336.01 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $249.31 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.82 | 2020-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $60.29 | 2019-2025 | Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $34.60 | 2024 | Arcalyst |
| Pfizer INC. | $28.04 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.56 | 2025 | Exparel |
| Medtronic Vascular, INC. | $17.11 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.49 | 2025 | Lifevest |
| Cordis US Corp. | $15.46 | 2022 | |
| Biotronik INC. | $13.21 | 2019 | |
| Irhythm Technologies, INC. | $12.83 | 2023 | Zio Xt Patch |
| Boston Scientific Corporation | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Fleisher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.